Arcus Biosciences (RCUS) Tops Q1 EPS by 95c

Arcus Biosciences (NYSE: RCUS) reported Q1 EPS of ($0.05), $0.95 better than the analyst estimate of ($1.00). Revenue for the quarter came in at $145 million versus the consensus estimate of $30.88 million.

For earnings history and earnings-related data on Arcus Biosciences (RCUS) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Verizon Communications (VZ) Tops Q2 EPS by 2c, Misses on Revenue, Tops on Postpaid Adds
• American Express (AXP) Tops Q2 EPS by 13c